Silicon Valley's Elite MedSpa Announces Innovative BHRT Treatments Utilizing SottoPelle Therapy®
SottoPelle® is a world recognized leader in the application of natural bioidentical hormones and natural hormone replacement therapy. Join Dr. Gino Tutera for an Informational Session: "Your Hormones, Your Health!" Thursday, October 25th, 2012 - 5:00 PM - Sheraton Palo Alto, 625 El Camino Real
Palo Alto, CA (PRWEB) October 25, 2012
The SottoPelle method for hormone replacement was scientifically created by Gino Tutera, M.D., F.A.C.O.G., who is an internationally renowned leader in the field of bioidentical (natural) hormone replacement.
"So Amazing!" That's what recipients of the SottoPelle® Bio-Identical Hormone Replacement Therapy are saying about the results they have experienced. If you can't remember why you walked into the room, are lacking a good night's sleep, suffering with hot flashes, night sweats and a lost libido, then SottoPelle® Therapy may be for you.
Come and learn more with guest speaker Dr. Gino Tutera, Founder and Medical Director of SottoPelle® Therapy, who has been changing the lives of thousands of men and women across the country who suffer from hormone deficiencies since 1992.
Elite MedSpa is one of Silicon Valley's Premier locations for Anti-Aging, Weight Loss, Wellness & Cosmetic Treatments. Elite MedSpa is located at LaBelle Day Spas & Salons at both the Palo Alto (Town & Country) and Stanford (Stanford Mall) locations.
Whether you are concerned about fine lines and wrinkles, weight loss, spider veins or hormonal balance the MedSpa team is there to assist you in reaching the results you want. Elite MedSpa's goal is to provide you with the highest level of custom service individualized for you.
Under the guidance of Dr. Richard H. German, MD, FACS, Elite MedSpa offers the following services: Medical Weight Loss, Laser Hair Removal, Bio-Identical Hormone Replacement Therapy, Cosmetic Botox, Juvederm, Latisse, IPL/Photofacial.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10055072.htmView Comments and Join the Discussion!